ATE311382T1 - Verfahren zur herstellung von 2-carbamoyl- pyridinen - Google Patents
Verfahren zur herstellung von 2-carbamoyl- pyridinenInfo
- Publication number
- ATE311382T1 ATE311382T1 AT99114893T AT99114893T ATE311382T1 AT E311382 T1 ATE311382 T1 AT E311382T1 AT 99114893 T AT99114893 T AT 99114893T AT 99114893 T AT99114893 T AT 99114893T AT E311382 T1 ATE311382 T1 AT E311382T1
- Authority
- AT
- Austria
- Prior art keywords
- pyridines
- carbamoyl
- producing
- carbamoylation
- concerned
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000021235 carbamoylation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000003222 pyridines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98114978 | 1998-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE311382T1 true ATE311382T1 (de) | 2005-12-15 |
Family
ID=8232437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99114893T ATE311382T1 (de) | 1998-08-10 | 1999-07-30 | Verfahren zur herstellung von 2-carbamoyl- pyridinen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6103902A (de) |
| EP (1) | EP0979822B1 (de) |
| JP (1) | JP3344972B2 (de) |
| KR (1) | KR100362081B1 (de) |
| CN (1) | CN1117746C (de) |
| AT (1) | ATE311382T1 (de) |
| CA (1) | CA2279796C (de) |
| DE (1) | DE69928610T2 (de) |
| DK (1) | DK0979822T3 (de) |
| ES (1) | ES2252894T3 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
| CN107531677A (zh) * | 2015-02-25 | 2018-01-02 | 法尔玛赞公司 | 用于制备托匹司他及其中间体的方法 |
| CN105669542A (zh) * | 2016-03-08 | 2016-06-15 | 南京师范大学 | 一种直接催化氧化法合成吡啶伯酰胺化合物的方法 |
| CA3197265A1 (en) * | 2020-11-05 | 2022-05-12 | Timo Rager | A stable crystalline hydrate of clazosentan disodium salt |
| EP4582086A3 (de) * | 2021-12-17 | 2025-07-23 | Idorsia Pharmaceuticals Ltd | Clazosentan-dinatriumsalz, dessen herstellung und pharmazeutische zusammensetzungen damit |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW313568B (de) * | 1994-12-20 | 1997-08-21 | Hoffmann La Roche |
-
1999
- 1999-07-30 EP EP99114893A patent/EP0979822B1/de not_active Expired - Lifetime
- 1999-07-30 ES ES99114893T patent/ES2252894T3/es not_active Expired - Lifetime
- 1999-07-30 AT AT99114893T patent/ATE311382T1/de active
- 1999-07-30 DE DE69928610T patent/DE69928610T2/de not_active Expired - Lifetime
- 1999-07-30 DK DK99114893T patent/DK0979822T3/da active
- 1999-08-06 CA CA002279796A patent/CA2279796C/en not_active Expired - Lifetime
- 1999-08-09 CN CN99117533A patent/CN1117746C/zh not_active Expired - Lifetime
- 1999-08-09 KR KR1019990032563A patent/KR100362081B1/ko not_active Expired - Lifetime
- 1999-08-09 US US09/370,817 patent/US6103902A/en not_active Expired - Lifetime
- 1999-08-10 JP JP22600399A patent/JP3344972B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3344972B2 (ja) | 2002-11-18 |
| US6103902A (en) | 2000-08-15 |
| CN1117746C (zh) | 2003-08-13 |
| CA2279796C (en) | 2003-09-30 |
| KR100362081B1 (ko) | 2002-11-23 |
| JP2000063377A (ja) | 2000-02-29 |
| ES2252894T3 (es) | 2006-05-16 |
| CA2279796A1 (en) | 2000-02-10 |
| DE69928610T2 (de) | 2006-08-10 |
| KR20000017194A (ko) | 2000-03-25 |
| EP0979822B1 (de) | 2005-11-30 |
| CN1245803A (zh) | 2000-03-01 |
| DK0979822T3 (da) | 2006-03-27 |
| EP0979822A1 (de) | 2000-02-16 |
| DE69928610D1 (de) | 2006-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69534029D1 (de) | Herstellung von Camptothecinderivaten durch intramolekulare Cyclisierung | |
| ATE174589T1 (de) | Verfahren zur herstellung von piperidinderivaten | |
| ATE145891T1 (de) | Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür | |
| DE3767672D1 (de) | Chinazolinonderivat und verfahren zu seiner herstellung. | |
| ATE442363T1 (de) | Verfahren zur herstellung von pyridinverbindungen | |
| ES543153A0 (es) | Metodo de preparar derivados de b-carbolin-3-oxadiazolilo | |
| ATE531702T1 (de) | Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür | |
| DE69231815D1 (de) | Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren | |
| ATE277915T1 (de) | Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen | |
| DE69928610D1 (de) | Verfahren zur Herstellung von 2-Carbamoyl-Pyridinen | |
| ATE115567T1 (de) | Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen. | |
| ATE278694T1 (de) | Verfahren zur herstellung von substituierte piperidinepoxiden | |
| DE69218414D1 (de) | Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten | |
| ATE315568T1 (de) | Verfahren zur herstellung antibakterieller verbindungen vom carbapenem-typ | |
| ATE92034T1 (de) | Verfahren zur herstellung von benzylaminen. | |
| ATE138376T1 (de) | Verfahren zur herstellung von benzylphthalazinonderivaten und von deren salzen | |
| ATE106397T1 (de) | Verfahren zur herstellung von 3,3- diarylacrylsäureamiden. | |
| ATE157971T1 (de) | Verfahren zur herstellung von aminotriazin- derivaten | |
| ATE365152T1 (de) | Verfahren zur herstellung fluorierter benzoesäuren | |
| ATE554094T1 (de) | Verfahren zur herstellung von 3-cephem- verbindungen | |
| ATE189453T1 (de) | Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen | |
| ATE299498T1 (de) | Verfahren zur herstellung von imidazolderivaten | |
| ATE159246T1 (de) | Verfahren zur herstellung von (s)-vinyl- und (s)- allenyl-gaba | |
| ATE223377T1 (de) | Verfahren zur herstellung von difluoracetophenon- derivaten | |
| ATE260264T1 (de) | Verfahren zur herstellung von oxazol-derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0979822 Country of ref document: EP |